Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.
Lau G, Obi S, Zhou J, Tateishi R, Qin S, Zhao H, Otsuka M, Ogasawara S, George J, Chow PKH, Cai J, Shiina S, Kato N, Yokosuka O, Oura K, Yau T, Chan SL, Kuang M, Ueno Y, Chen M, Cheng AL, Cheng G, Chuang WL, Baatarkhuu O, Bi F, Dan YY, Gani RA, Tanaka A, Jafri W, Jia JD, Kao JH, Hasegawa K, Lau P, Lee JM, Liang J, Liu Z, Lu Y, Pan H, Payawal DA, Rahman S, Seong J, Shen F, Shiha G, Song T, Sun HC, Masaki T, Sirachainan E, Wei L, Yang JM, Sallano JD, Zhang Y, Tanwandee T, Dokmeci A, Zheng SS, Fan J, Fan ST, Sarin SK, Omata M. Lau G, et al. Among authors: tanaka a. Hepatol Int. 2024 Nov 21. doi: 10.1007/s12072-024-10732-z. Online ahead of print. Hepatol Int. 2024. PMID: 39570557
Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study.
Tanaka A, Teranishi S, Kajita Y, Hirose T, Kaneko A, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Miura K, Kobayashi N, Yamamoto M, Nishihira R, Kudo M, Miyazawa N, Nishikawa M, Kaneko T. Tanaka A, et al. Front Oncol. 2024 Nov 4;14:1400277. doi: 10.3389/fonc.2024.1400277. eCollection 2024. Front Oncol. 2024. PMID: 39558947 Free PMC article.
Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study.
Yasuda M, Shiokawa M, Kuwada T, Nishikawa Y, Nakanishi R, Takimoto I, Chikugo K, Yokode M, Muramoto Y, Matsumoto S, Nakamura T, Ota S, Matsumori T, Kuroda K, Hachiya T, Yamazaki H, Uza N, Kodama Y, Chiba T, Fujisawa T, Komori A, Abe M, Yamaguchi I, Matsuda F, Isayama H, Tanaka A, Seno H; Japan PSC Study Group (JPSCSG). Yasuda M, et al. Among authors: tanaka a. J Gastroenterol. 2024 Nov 16. doi: 10.1007/s00535-024-02169-w. Online ahead of print. J Gastroenterol. 2024. PMID: 39549066
6,363 results